Loyal
Loyal develops medicines intended to extend dogs’ lifespans.
$100MSeries C
Role not disclosedVE
Valor Equity Partners
Activity from announced rounds
Activity in this selectionFeb 28, 2026 · Feb 1, 2026
Valor Equity Partners invests in technology and technology-enabled businesses, using an operational growth model shaped by work in industrial companies, logistics, food and healthcare.
The firm’s operating work centres on improving how a business produces and delivers: warehouse workflows, assembly lines, restaurant operations and other processes that determine capacity and efficiency. It combines early-stage and growth investment activity.
Valor’s history in tech-enabled industrial businesses makes it particularly relevant when a founder must scale physical operations alongside a technology product. The investment relationship can include direct work on production processes and operating performance.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $585M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionFundamental
Provides a Large Tabular Model to drive predictions from enterprise data
$255MSeries A
Role not disclosedPositron AI
Positron AI develops memory-focused hardware and software for large-language-model inference.
$230MSeries B
Role not disclosed